What is periodic review in GMP?

Short answer

Periodic review in GMP is a planned, evidence-based assessment used to confirm that a system, process, facility, utility, equipment item, document set or quality control remains suitable, current and effective. It helps detect drift, evaluate accumulated changes and decide whether continued use, improvement, requalification, revalidation or retirement is justified.

What should periodic review cover?

The scope should be defined for the subject being reviewed. Examples include qualified cleanrooms and utilities, validated processes, computerised systems, analytical methods, controlled documents, contamination-control measures and other elements that support product quality or the validated state.

A useful review looks beyond the original qualification or approval package. It tests whether the current operation, configuration and supporting evidence still match the approved state.

How often should periodic review be performed?

The frequency should be documented and justified using risk, regulatory expectations, system criticality, performance history and the rate of change. Some reviews are calendar-based; others may be brought forward by significant change, adverse trend, repeated deviation, audit finding, obsolescence or new regulatory information.

A fixed annual frequency is not automatically suitable for every subject. The organisation should be able to explain why the interval is appropriate and what would trigger an earlier review.

What information should be examined?

• changes, deviations, investigations and CAPA since the previous review;

• qualification, validation and ongoing process-verification results;

• calibration, maintenance, breakdown, alarm and equipment-performance history;

• environmental, utility, process and product-quality trends;

• audit, self-inspection, complaint and regulatory inspection findings;

• training, access, data-integrity and procedural-compliance evidence;

• supplier, service-provider and technical-support performance where relevant; and

• new risks, standards, obsolescence or changes in intended use.

What decisions should the review produce?

The conclusion should state whether the subject remains fit for intended use and adequately controlled. Where gaps are identified, the review should define their significance, required actions, owners and timescales.

Possible outcomes include continued use without change, targeted improvement, updated documentation, additional monitoring, repair, upgrade, requalification, partial or full revalidation, use restrictions or controlled retirement.

Periodic review is not the same as routine monitoring

Routine monitoring detects current performance signals. Periodic review brings the accumulated evidence together and makes a documented lifecycle decision. Product Quality Review is a specific GMP review of products and processes; it may provide important inputs but does not replace subject-specific reviews of systems, facilities or computerised applications.

What evidence should be retained?

A defensible record normally includes the approved scope and review interval, reviewers and approvers, evidence examined, trend analysis, unresolved issues, risk assessment, conclusion and linked actions. The record should show how conflicting or incomplete evidence was handled and why the final decision is scientifically justified.

Common weaknesses

• The review is a checklist exercise with no meaningful assessment of trends.

• The current configuration is not compared with the approved or validated state.

• Open deviations, CAPA or changes are omitted from the review.

• Review intervals are copied from precedent without a risk-based rationale.

• Actions are recorded but not governed through change control, CAPA or management review.

Questions to ask internally

• Is the review scope linked to intended use and critical quality risks?

• Can every important change since the previous review be reconstructed?

• Do current trends support continued confidence in control?

• Are conclusions explicit, approved and linked to accountable follow-up?

How W2 Cleanroom Consulting can help

W2 Cleanroom Consulting can independently review periodic-review strategy, risk-based intervals, evidence packages, validated-state assessments and follow-up plans for cleanrooms, facilities, utilities, processes and quality systems. The client remains responsible for quality approvals, lifecycle decisions and regulatory compliance.

Related GxP knowledge

• What is validation lifecycle management?

• What is change control in GMP?

• What is management review in GMP?

• What is self-inspection in GMP?

Need an independent periodic review or validated-state assessment? Contact W2 Cleanroom Consulting.

Prepared and reviewed by: W2 Cleanroom Consulting GMP team. Last reviewed: 24 July 2026.